UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 

FORM 8-K
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  September 9, 2010
 
 


MICRUS ENDOVASCULAR CORPORATION
(Exact name of registrant as specified in its charter)
 
 
         
Delaware
 
000-51323
 
23-2853441
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)

     
821 Fox Lane, San Jose, California
 
95131
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (408) 433-1400
 
Not applicable
(Former name or former address, if changed since last report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
   

 
 
 

ITEM 8.01.                      OTHER EVENTS.
 
On September 9, 2010, Micrus Endovascular Corporation was informed that it had received approval from the People’s Republic of China State Food and Drug Administration (SFDA) to market its bare platinum, non-stretch resistant microcoils in China.
 

 
 
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
MICRUS ENDOVASCULAR CORPORATION
   
   
Date:  September 13, 2010
By:
/s/ Gordon T. Sangster
   
Name:
Gordon T. Sangster
   
Title:
Chief Financial Officer



Micrus Endovascular (MM) (NASDAQ:MEND)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Micrus Endovascular (MM)
Micrus Endovascular (MM) (NASDAQ:MEND)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Micrus Endovascular (MM)